Topoisomerase I inhibitors: Challenges, progress and the road ahead
A Talukdar, B Kundu, D Sarkar, S Goon… - European Journal of …, 2022 - Elsevier
Abstract Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is
expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in …
expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in …
DNA topoisomerases as molecular targets for anticancer drugs
K Buzun, A Bielawska, K Bielawski… - Journal of Enzyme …, 2020 - Taylor & Francis
The significant role of topoisomerases in the control of DNA chain topology has been
confirmed in numerous research conducted worldwide. The prevalence of these enzymes …
confirmed in numerous research conducted worldwide. The prevalence of these enzymes …
Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications
J Li, A Gu, XM Nong, S Zhai, ZY Yue… - The Chemical …, 2023 - Wiley Online Library
Cancer stands as a serious malady, posing substantial risks to human well‐being and
survival. This underscores the paramount necessity to explore and investigate novel …
survival. This underscores the paramount necessity to explore and investigate novel …
The design and discovery of topoisomerase I inhibitors as anticancer therapies
E Martín-Encinas, A Selas, F Palacios… - Expert Opinion on Drug …, 2022 - Taylor & Francis
Introduction Cancer has been identified as one of the leading causes of death worldwide.
The biological target of some anticancer agents is topoisomerase I, an enzyme involved in …
The biological target of some anticancer agents is topoisomerase I, an enzyme involved in …
Design, synthesis, and biological evaluation of 3, 3′-diindolylmethane N-linked glycoconjugate as a leishmanial topoisomerase IB inhibitor with reduced cytotoxicity
Leishmaniasis, one of the neglected diseases, ranks second to malaria in the cause of
parasitic mortality and morbidity. The present chemotherapeutic regimen faces the …
parasitic mortality and morbidity. The present chemotherapeutic regimen faces the …
Copper(I)-Catalyzed Nitrile-Addition/N-Arylation Ring-Closure Cascade: Synthesis of 5,11-Dihydro-6H-indolo[3,2-c]quinolin-6-ones as Potent Topoisomerase-I …
WY Hsueh, YSE Lee, MS Huang, CH Lai… - Journal of Medicinal …, 2021 - ACS Publications
In this paper, we present a copper (I)-catalyzed nitrile-addition/N-arylation ring-closure
cascade for the synthesis of 5, 11-dihydro-6 H-indolo [3, 2-c] quinolin-6-ones from 2-(2 …
cascade for the synthesis of 5, 11-dihydro-6 H-indolo [3, 2-c] quinolin-6-ones from 2-(2 …
[HTML][HTML] Natural compounds as therapeutic agents: The case of human topoisomerase ib
A Ottaviani, F Iacovelli, P Fiorani… - International Journal of …, 2021 - mdpi.com
Natural products are widely used as source for drugs development. An interesting example
is represented by natural drugs developed against human topoisomerase IB, a ubiquitous …
is represented by natural drugs developed against human topoisomerase IB, a ubiquitous …
Emerging roles of DNA topoisomerases in the regulation of R-loops
PS Patel, R Krishnan, R Hakem - Mutation Research/Genetic Toxicology …, 2022 - Elsevier
R-loops are comprised of a DNA: RNA hybrid and a displaced single-strand DNA (ssDNA)
that reinvades the DNA duplex behind the moving RNA polymerase. Because they have …
that reinvades the DNA duplex behind the moving RNA polymerase. Because they have …
G-quadruplex-containing oligodeoxynucleotides as DNA topoisomerase I inhibitors
D Li, X Chen, R Yan, Z Jiang, B Zhou, B Lv - International Journal of …, 2022 - Elsevier
DNA topoisomerase I was found to be highly abundant in fast-proliferating tumor cells and is
a potential target for anticancer therapy. A series of G-quadruplex-containing …
a potential target for anticancer therapy. A series of G-quadruplex-containing …